ZenBio Licenses Metabolic Cell Line from Harvard | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – ZenBio today said that it has licensed rights from Harvard University to become a commercial source for the murine 3T3-L1 cell line for use in metabolic research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.